The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Histologic and genotypic re-evaluation of non-small cell lung cancer (NSCLC): A monocentric study.
Tiziana Vavalá
No relevant relationships to disclose
Marco Busso
No relevant relationships to disclose
Luisella Righi
No relevant relationships to disclose
Simona Vatrano
No relevant relationships to disclose
Susanna Cappia
No relevant relationships to disclose
Diego Sardo
No relevant relationships to disclose
Simonetta Grazia Rapetti
No relevant relationships to disclose
Andrea Veltri
Honoraria - Bayer; Lilly
Mauro Papotti
No relevant relationships to disclose
Giorgio Vittorio Scagliotti
Honoraria - AstraZeneca; Lilly; Pfizer; Roche
Silvia Novello
No relevant relationships to disclose